Review
Copyright ©2013 Baishideng Publishing Group Co.
World J Immunol. Jul 27, 2013; 3(2): 18-30
Published online Jul 27, 2013. doi: 10.5411/wji.v3.i2.18
Table 1 A summary of clinically relevant antibodies targeted against glycolipid and glycoprotein-related saccharides
Neuropathy syndromeAntibody targetAntibody isotype
Chronic Sensory-Motor demyelinatingMyelin-associated glycoprotein SulfoglucuronylparaglobosideIgM (monoclonal)
Chronic ataxic neuropathyGD1b, GQ1bIgM (monoclonal)
Multifocal Motor neuropathyGM1, GM2, GD1bIgM (polyclonal or monoclonal)
Sensory neuropathySulfatideIgM (monoclonal or polyclonal)
Acute motor axonal neuropathyGM1, GD1a, GalNAc GD1a, GM1bIgG
Acute inflammatory demyelinating polyneuropathyVariableVariable
Miller-Fisher syndromeGQ1b ("anti-GQ1b antibody syndrome"), GT1aIgG
Bickerstaff's brainstem encephalitis
Acute ophthalmoparesis
Ataxic Guillain-Barré syndrome
Pharyngeal-cervical-brachial weaknessGT1a (GQ1b)IgG
Amyotrophic lateral sclerosisGM1IgG